Altaris Capital Partners Acquires Intricon Corporation

Altaris Capital Partners Majority Recapitalizes Minnetronix Medical

February 3, 2021

Medical Devices

Altaris Capital Partners has completed a majority recapitalization of Minnetronix Medical, expanding a relationship in place since 2015 when Altaris was a minority investor. The transaction provides Minnetronix — a Saint Paul, Minnesota-based medical device product development and contract manufacturing partner — with capital and partnership support to accelerate its growth and product strategy.

Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer

December 30, 2021

Medical Devices

Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.

Altaris Acquires Sharecare

June 25, 2024

Healthcare Services

Altaris, a healthcare-focused investment firm, agreed to acquire publicly traded digital health company Sharecare in a take-private transaction at $1.43 per share. The deal will take Sharecare private (stockholders approved the transaction) and positions the company to operate as a standalone portfolio company under Altaris to accelerate growth and product/service development.

Altaris Acquires Minaris Regenerative Medicine from Resonac

September 23, 2024

Healthcare Services

Altaris, LLC has acquired Minaris Regenerative Medicine from Resonac Corporation, making Minaris a wholly owned portfolio company of Altaris. Minaris is a cell therapy CDMO with six facilities across the United States, Germany and Japan and more than 500 employees; the deal advances Altaris' strategic initiative to build capabilities in cell and gene therapy manufacturing.

Nordic Capital-Led Consortium Acquires Inovalon

November 24, 2021

Healthcare Services

An equity consortium led by Nordic Capital, joined by Insight Partners, 22C Capital and Inovalon founder Keith Dunleavy, completed the acquisition of Inovalon in a take-private transaction. Inovalon stockholders received $41.00 per share in cash as the cloud-based healthcare data and analytics provider is taken private to accelerate product innovation and expand its reach across the healthcare ecosystem.

Nordson Corporation to Acquire Atrion Corporation

May 28, 2024

Medical Devices

Nordson Corporation has entered into a definitive agreement to acquire Atrion Corporation for $460.00 per share in cash, representing an aggregate enterprise value of approximately $800 million. The acquisition expands Nordson's medical portfolio into infusion and cardiovascular therapies and is expected to close prior to Nordson's fiscal year-end 2024, subject to regulatory and stockholder approvals.